Skip to main content

Table 2 Model clinical parameters values: base case

From: Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain

Parameter

Value

Annual number of hospital surgical procedures

733,876

Procedures utilizing an NMBA

73.3%

Type of block

Moderate: 80%

Deep: 20%

Reversal agent use (neostigmine)

No reversal agent:

Reversal agent:

No reversal agent:

Reversal agent:

68.0%

32.0%

68.0%

32.0%

Instances with use of rocuronium

64.0%

43.5%

64.0%

43.5%

Instances with use of cisatracurium

25.0%

25.0%

25.0%

25.0%

Instances with use of other agents

11.0%

31.5%

11.0%

31.5%

Proportion of instances where cisatracurium switched to rocuronium

50.0%

50.0%

50.0%

50.0%

 

Neostigmine / No reversal agent

Sugammadex

Risk of post-operative atelectasis

7.3%

1.1%

Risk of post-operative pneumonia

4.0%

1.9%